Results 191 to 200 of about 3,909 (222)
Some of the next articles are maybe not open access.
IMPACT OF TERLIPRESSIN ON RENAL GRAFT FUNCTION
Shock, 2008To assess the effect of a bolus of terlipressin in brain-dead donors with shock refractory to norepinephrine, a retrospective study was conducted in a 16-bed intensive care unit of a university hospital. Twenty brain-dead donors were treated with norepinephrine within the study period.
A. Geissler +5 more
openaire +3 more sources
Terlipressin for hepatorenal syndrome
Current Opinion in GastroenterologyPurpose of review The definition and diagnostic criteria of hepatorenal syndrome-acute kidney injury (HRS-AKI) has undergone recent changes. A major vasoconstrictor, terlipressin, has recently been approved as pharmacotherapy for HRS-AKI in the United States.
openaire +2 more sources
The use of terlipressin in hepatorenal syndrome
Dialysis & Transplantation, 2010AbstractHepatorenal syndrome (HRS) is a potentially reversible cause of acute renal failure that occurs in patients with hepatic failure resulting from advanced cirrhosis. It is characterized by impaired kidney function in the setting of normal renal parenchyma, alterations in cardiovascular function, splanchnic vasodilation, and overactivity of the ...
Inna Rozov‐Ung, Mandip Panesar
openaire +2 more sources
[The role of terlipressin in hepatorenal syndrome].
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2010Hepatorenal syndrome (HRS) is a severe complication in patients with endstage liver disease. It consists of functional renal vasoconstriction leading to severe reduction of the glomerular filtration rate. In some patients the renal failure shows a rapidly progressive course, a clinical pattern known as type 1 HRS.
FORCELLINI, Silvia, FABBIAN, Fabio
openaire +2 more sources
Terlipressin-Induced Skin Necrosis and Rhabdomyolysis
The American Journal of the Medical Sciences, 2010CLINICAL PRESENTATION A 54-year-old man without known cardiovascular diseases was referred for alcoholic cirrhosis with jaundice and tense ascites. Laboratory data were significant for creatinine 2.5 mg/dL, bilirubin 4.5 mg/dL, C-reactive protein 79 mg/L and international normalized ratio 2.6.
Frank Lammert, Vincent Zimmer
openaire +3 more sources
Preparation and characterization of PEGylated terlipressin
Journal of Applied Polymer Science, 2010AbstractTerlipressin was chemically modified by reaction with succinimidyl propionate‐ monomethoxy polyethylene glycol (mPEG‐SPA). To determine the PEGylated degree, the position and the optimized condition for PEGylated terlipressin, the reactions were monitored in different pH value buffers at different molar ratios by reversed‐phase high performance
Hansen Lin +3 more
openaire +2 more sources
Terlipressin therapy for renal failure in cirrhosis
European Journal of Gastroenterology & Hepatology, 2010Renal failure is common in cirrhosis frequently due to hepatorenal syndrome (HRS). Terlipressin and albumin improve renal function with a trend to prolong survival in HRS, but prognostic factors with therapy have been poorly studied.Forty-five cirrhotics seen consecutively in a single centre with renal failure defined as oliguria/anuria and/or rising ...
Laura Marelli +8 more
openaire +3 more sources
Terlipressin: Leading the Water to the Thirsty*
Critical Care Medicine, 2022Rahul S, Nanchal, Stephen, Warrillow
openaire +2 more sources
Terlipressin-exacerbated hypokalaemia
The Lancet, 1998Françoise Paillard, François Stéphan
openaire +3 more sources